Pasiūlymai

Daugiau pasiūlymų, puslapis 40322

Visi žemiau esantys pasiūlymai turi 13–97% nuolaidą. Kainos sinchronizuojamos realiu laiku iš patikrintų parduotuvių.

Shenzhen Kinwong Electronic Co., Ltd. (603228.SS): SWOT Analysis [Dec-2025 Updated]
-22%

Shenzhen Kinwong Electronic Co., Ltd. (603228.SS): SWOT Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Shenzhen Kinwong Electronic Co., Ltd. (603228.SS): PESTLE Analysis [Dec-2025 Updated]
-22%

Shenzhen Kinwong Electronic Co., Ltd. (603228.SS): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Shenzhen Kinwong Electronic Co., Ltd. (603228.SS): Marketing Mix Analysis
-22%

Shenzhen Kinwong Electronic Co., Ltd. (603228.SS): Marketing Mix Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Shenzhen Kinwong Electronic Co., Ltd. (603228.SS): 5 FORCES Analysis [Dec-2025 Updated]
-22%

Shenzhen Kinwong Electronic Co., Ltd. (603228.SS): 5 FORCES Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Shenzhen Kinwong Electronic Co., Ltd. (603228.SS): VRIO Analysis
-22%

Shenzhen Kinwong Electronic Co., Ltd. (603228.SS): VRIO Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS): Ansoff Matrix
-22%

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS): Ansoff Matrix

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS): Canvas Business Model
-22%

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS): Canvas Business Model

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS): BCG Matrix [Dec-2025 Updated]
-22%

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS): BCG Matrix [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) DCF Valuation
-40%

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) DCF Valuation

dcfmodeling.comPLPL
15,00 PLN25,00 PLN
Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS): PESTLE Analysis [Dec-2025 Updated]
-22%

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS): Marketing Mix Analysis
-22%

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS): Marketing Mix Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS): 5 FORCES Analysis [Dec-2025 Updated]
-22%

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS): 5 FORCES Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS): SWOT Analysis [Dec-2025 Updated]
-22%

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS): SWOT Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS): BCG Matrix [Dec-2025 Updated]
-22%

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS): BCG Matrix [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS): Ansoff Matrix
-22%

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS): Ansoff Matrix

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS): VRIO Analysis
-22%

Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS): VRIO Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS): Canvas Business Model
-22%

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS): Canvas Business Model

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS): PESTLE Analysis [Dec-2025 Updated]
-22%

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS): PESTLE Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS): Marketing Mix Analysis
-22%

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS): Marketing Mix Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS): 5 FORCES Analysis [Dec-2025 Updated]
-22%

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS): 5 FORCES Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) DCF Valuation
-40%

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) DCF Valuation

dcfmodeling.comPLPL
15,00 PLN25,00 PLN
Quectel Wireless Solutions Co., Ltd. (603236.SS): Ansoff Matrix
-22%

Quectel Wireless Solutions Co., Ltd. (603236.SS): Ansoff Matrix

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS): VRIO Analysis
-22%

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS): VRIO Analysis

dcfmodeling.comPLPL
7,00 PLN9,00 PLN
DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS): SWOT Analysis [Dec-2025 Updated]
-22%

DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS): SWOT Analysis [Dec-2025 Updated]

dcfmodeling.comPLPL
7,00 PLN9,00 PLN